These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19050344)

  • 1. Comments on Delanghe and Joyner's editorial "testing for recombinant human erythropoietin". Preanalytical and analytical issues in indirect hematological testing.
    Lippi G; Banfi G
    J Appl Physiol (1985); 2008 Dec; 105(6):1990-1. PubMed ID: 19050344
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on Delanghe and Joyner's editorial "testing for recombinant human erythropoietin".
    Skibeli V
    J Appl Physiol (1985); 2008 Dec; 105(6):1990-1. PubMed ID: 19140253
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on Delanghe and Joyner's editorial "testing for recombinant human erythropoietin". The importance of a strong collaboration between pharmaceutical companies and WADA-accredited laboratories.
    Mørkeberg J; Belhage B; Damsgaard R
    J Appl Physiol (1985); 2008 Dec; 105(6):1990-1. PubMed ID: 19140252
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". Anti-doping testing: friend or foe?
    Lippi G
    J Appl Physiol (1985); 2008 Dec; 105(6):1992; author reply 1997-8. PubMed ID: 19050345
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". New strategies in the fight against doping are necessary.
    Schumacher YO; Pottgiesser T
    J Appl Physiol (1985); 2008 Dec; 105(6):1994; author reply 1997-8. PubMed ID: 19140259
    [No Abstract]   [Full Text] [Related]  

  • 6. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". Testing for recombinant human erythropoietin--the bouquet of compounds.
    Jelkmann WE
    J Appl Physiol (1985); 2008 Dec; 105(6):1992; author reply 1997-8. PubMed ID: 19140254
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". A negative test cannot exclude doping.
    Kayser B
    J Appl Physiol (1985); 2008 Dec; 105(6):1993; author reply 1997-8. PubMed ID: 19140257
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing".
    Skibeli V
    J Appl Physiol (1985); 2008 Dec; 105(6):1995; author reply 1997-8. PubMed ID: 19140261
    [No Abstract]   [Full Text] [Related]  

  • 9. No proof for augmented arterial oxygen content as only factor influencing exercise capacity after Epo doping.
    Böning D; Maassen N; Pries A
    J Appl Physiol (1985); 2008 Dec; 105(6):1988; author reply 1989. PubMed ID: 19050342
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing".
    Saugy M; Robinson N; Lamon S
    J Appl Physiol (1985); 2008 Dec; 105(6):1995-6; author reply 1997-8. PubMed ID: 19140262
    [No Abstract]   [Full Text] [Related]  

  • 11. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing".
    Lasne F
    J Appl Physiol (1985); 2008 Dec; 105(6):1993-4; author reply 1997-8. PubMed ID: 19140258
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing".
    Valeri CR; Ragno G
    J Appl Physiol (1985); 2008 Dec; 105(6):1993; author reply 1997-8. PubMed ID: 19140256
    [No Abstract]   [Full Text] [Related]  

  • 13. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". Expanding the analysis reporting will lead to more efficient testing.
    Mørkeberg J; Belhage B; Damsgaard R
    J Appl Physiol (1985); 2008 Dec; 105(6):1994-5; author reply 1997-8. PubMed ID: 19140260
    [No Abstract]   [Full Text] [Related]  

  • 14. Testing for recombinant human erythropoietin.
    Delanghe JR; Joyner MJ
    J Appl Physiol (1985); 2008 Aug; 105(2):395-6. PubMed ID: 18583374
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". Problems associated with current anti-doping testing: is quality assessment a reliable solution?
    Salvagno GL; Guidi GC
    J Appl Physiol (1985); 2008 Dec; 105(6):1992-3; author reply 1997-8. PubMed ID: 19140255
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on Lundby et al.'s "testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing". Comment of laboratory B on the publication by Lundby et al.
    Schänzer W; Geyer H
    J Appl Physiol (1985); 2008 Dec; 105(6):1996; author reply 1997-8. PubMed ID: 19140263
    [No Abstract]   [Full Text] [Related]  

  • 17. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion.
    Reichel C
    Drug Test Anal; 2012 Nov; 4(11):803-4. PubMed ID: 22927317
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of exercise on the secondary blood markers commonly used to suspect erythropoietin doping.
    Robinson N; Saugy M; Mangin P
    Clin Lab; 2003; 49(1-2):57-62. PubMed ID: 12593476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.